FDA Brief

Company record

Lexia LLC

1 FDA warning letter since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Lexia LLC.

Warning letters

  1. Lexia LLC

    FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.

    High risk

Recalls

ReportedClassFirmProduct and reason
Sep 9 Class II Lexia LLC
Drug
Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolate, 1000mg Hempseed oil, 2 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-5, UPC 8 50041 64003 7
CGMP Deviations: Potential contamination of raw material
Sep 9 Class II Lexia LLC
Drug
Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's, Franklin, TN, 37067, NDC 83088-8120-6; UPC 8 50041 64004 4
CGMP Deviations: Potential contamination of raw material